Drug intelligence / Profile preview

mucopolysaccharide polysulphate

Development stage
Phase 4
Administration
Topical
01

Overview

Mucopolysaccharide polysulphate (MPS) is a topical medication, a complex carbohydrate polymer, used for its anti-inflammatory, antithrombotic, and tissue-regenerating properties. It is similar to naturally occurring mucopolysaccharides found in the skin. MPS is utilized in the treatment of various conditions including xerosis in atopic dermatitis, bruises, superficial thrombophlebitis, varicose veins, and to improve scar formation. Its mechanism of action involves enhancing blood circulation, preventing blood clot formation by inhibiting thrombin and factor Xa, reducing inflammation and swelling, and promoting tissue healing. In the context of skin barrier function, it repairs tight junction dysfunction by increasing the expression of claudin-1 and zonula occludens-1, and inactivating the extracellular signal-regulated kinase signaling pathway. It also contributes to skin hydration and elasticity by stimulating endogenous hyaluronate synthesis and inhibits collagen fiber hyperplasia and type I collagen expression in scar formation.

Brand names
喜辽妥Hirudoid
Other names
MPSorgano-heparinoid "Luitpold"heparinoid
02

Targets

CLDN1 (Tight junction protein claudin-1)F10 (Factor Xa)F2 (Thrombin)TJP1 (Tight junction protein 1 (ZO-1))ERKHAS1 (Hyaluronan synthase 2)COL1 (Collagen type I)

Beyond the preview

Go deeper on mucopolysaccharide polysulphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mucopolysaccharide polysulphate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call